Weaker Buy Today ALNY ranks #1397 as BUY CANDIDATE #1397 Stronger Buy

ALNY stock forecast Alnylam Pharmaceuticals

ALNY stock forecast

Wednesday December 11, 2019 Change -2.50% Price $118.79
Your prediction: Prediction: Request



Bullish vs. Bearish (1 opinions)
Social Sentiment 0.00

ALNY Forecast and Technical Stock Analysis

Buy candidate since 2019-12-10 Loss -2.50% PDF

Alnylam Pharmaceuticals fell by -2.50% in the last day ( Wednesday, 11th Dec 2019 ) from $121.84 to $118.79 During the day the stock fluctuated 3.85% from a day low at $117.79 to a day high of $122.33. The price has fallen in 6 of the last 10 days and is down by -0.23% for this period. Volume fell in the last day along with the stock, which is actually a good sign as volume should follow the stock. In the last day the trading volume fell by -175 781 shares and in total 517 416 shares bought and sold for approximately $61.46 million.

Quick summary:

  • 30 day high of the ALNY stock price was $125.72 and low was $88.93.
  • 90 day high was $125.72 and low was $73.32.
  • 52 week high for Alnylam Pharmaceuticals - $125.72 and low - $60.27.
Top Trending Stocks


Alnylam Pharmaceuticals lies in the middle of a wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 49.91% during the next 3 months and, with 90% probability hold a price between $162.63 and $192.78 at the end of this period.

Top Golden Star Stocks


Alnylam Pharmaceuticals holds a sales signal from the short-term moving average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock. On further gains, the stock will meet resistance from the short-term moving average at approximately $121.95. On a fall, the stock will find some support from the long-term average at approximately $102.34. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sales signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sales signal was issued from a pivot top point on Thursday December 05, 2019, which indicates further falls until a new bottom pivot has been found. Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Access today's Top 5 Golden Star Companies

Relative Strength Index (RSI)

RSImin/max Values: [ 25 - 75 ]

RSI14 is 64 and the stock is currently not being overbought or oversold

* Stockinvest.us uses dynamical calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behaviour.

Support & Resistance

On the downside, the stock finds support just below today's level from accumulated volume at $112.42 and $111.20.

There is natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Alnylam Pharmaceuticals finds support just below today's level at $112.42. If this is broken, then the next support from accumulated volume will be at $111.20 and $108.21.

Support: $112.42 Price: $118.79 Resistance: $119.06


This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $4.54 between high and low, or 3.85%. For the last week, the stock has had a daily average volatility of 3.35%.

Our recommended stop-loss: $111.09 (-6.48%) (This stock has very high daily movements and this gives very high risk. There is a sell signal from pivot top found 4 day(s) ago.)

3.35 %

Average volatility

Overall risk:

Very Low Low Medium High Very High

Buy Candidate Upgraded


Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for this stock to perform well in the short-term.

Weaker Buy Today ALNY ranks #1397 as BUY CANDIDATE #1397 Stronger Buy
Exchange: NASDAQ | NYSE | XLON | AMS | TSX | BRU

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 8.000 stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

Proudly made at